| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/29/2004 | US20040018190 Drugs and foods improving the quality of life and process for producing the same |
| 01/29/2004 | US20040018171 Biochemical conjugates comprising tumor necrosis factor or interferons and ligands of CD antigen receptors, used as anticarcinogenic agents |
| 01/29/2004 | US20040017387 Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
| 01/29/2004 | US20040016532 Cooling apparatus |
| 01/29/2004 | US20040016427 Method and apparatus for generating an aerosol |
| 01/29/2004 | DE19952982B4 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |
| 01/29/2004 | DE10224108A1 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung 1-dimethylamino-3- (3-methoxy-phenyl) -2-methyl-pentan-3-ol-containing sustained release Arzneimiitel |
| 01/29/2004 | CA2493674A1 Dendrimers as molecular translocators |
| 01/29/2004 | CA2493252A1 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 01/29/2004 | CA2492878A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/29/2004 | CA2492862A1 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | CA2492806A1 Targeted agents for nerve regeneration |
| 01/29/2004 | CA2492754A1 Compositions and products containing enantiomeric equol, and methods for their making |
| 01/29/2004 | CA2492472A1 Use of urease for inhibiting cancer cell growth |
| 01/29/2004 | CA2489008A1 Ghrelin-carrier conjugates |
| 01/29/2004 | CA2487849A1 Hapten-carrier conjugates comprising virus like particles and uses thereof |
| 01/28/2004 | EP1384774A1 Glycosaminoglycan/collagen complexes and use thereof |
| 01/28/2004 | EP1384710A1 Synthesis of heterocyclic compounds containing five- or six-membered rings |
| 01/28/2004 | EP1384488A2 Method and kit for imaging organs and tissues, using labelled antibodies |
| 01/28/2004 | EP1384474A1 Injectable composition containing taxol |
| 01/28/2004 | EP1384472A1 Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate |
| 01/28/2004 | EP1384471A1 Osmotic extented-release dosage form |
| 01/28/2004 | EP1384081A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383816A1 Film-forming composition for topical use and use thereof for delivering active agents |
| 01/28/2004 | EP1383801A1 Antibodies against cancer |
| 01/28/2004 | EP1383782A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication |
| 01/28/2004 | EP1383778A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 01/28/2004 | EP1383738A2 Alkyl and/or alkenyl glycerol carbamates |
| 01/28/2004 | EP1383544A1 Anti-cd19 immunotoxins |
| 01/28/2004 | EP1383541A1 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 01/28/2004 | EP1383539A1 Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 01/28/2004 | EP1383537A1 Novel chocolate composition as delivery system for nutrients and medications |
| 01/28/2004 | EP1383529A2 Methods of treating disorders of the eye and surrounding tissue with thymosin 4 (t 4), analogues, isoforms and other derivatives |
| 01/28/2004 | EP1383522A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 01/28/2004 | EP1383521A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/28/2004 | EP1383520A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/28/2004 | EP1383519A2 Treatment solution used for caring for wounds in addition to dressing material for use with said treatment solution |
| 01/28/2004 | EP1383518A1 Oral delivery of macromolecules |
| 01/28/2004 | EP1383516A1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 01/28/2004 | EP1383510A1 Bisphosphonate conjugates and methods of making and using the same |
| 01/28/2004 | EP1383504A1 Sustained release drug delivery system containing codrugs |
| 01/28/2004 | EP1383502A2 Compounds and methods for the treatment of urogenital disorders |
| 01/28/2004 | EP1383492A1 Molecular conjugates for use in treatment of cancer |
| 01/28/2004 | EP1383485A1 Gastric juice-resistant device for releasing mucoadhesive active substance excipients and method for producing this gastric juice-resistant device |
| 01/28/2004 | EP1383483A1 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 01/28/2004 | EP1383482A2 Method for manufacturing a low dose pharmaceutical composition |
| 01/28/2004 | EP1383481A1 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 01/28/2004 | EP1383480A2 Lipid-comprising drug delivery complexes and methods for their production |
| 01/28/2004 | EP1383464A1 Nail compositions and methods of administering same |
| 01/28/2004 | EP1383445A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 01/28/2004 | EP1383377A1 Compositions including vitamin-based surfactants and methods for using same |
| 01/28/2004 | EP1383376A2 Pharmaceutical formulations for sustained release |
| 01/28/2004 | EP1383375A1 A release pharmaceutical construct for gastric retention |
| 01/28/2004 | EP1345589A4 Solvent systems for pharmaceutical agents |
| 01/28/2004 | EP1307097A4 Improved solid pharmaceutical dosage formulation of hydrophobic drugs |
| 01/28/2004 | EP1296676B1 Use of indole-3-acetic acid derivatives in medicine |
| 01/28/2004 | EP1217990B1 Cationic dosper virosomes |
| 01/28/2004 | EP1214077B1 Local delivery of 17-beta estradiol for improving vascular endothelium function after vascular injury |
| 01/28/2004 | EP1214066A4 Formation of nanometer-scale structures |
| 01/28/2004 | EP1089718B1 Sticking plaster for controlled release of natural interferon |
| 01/28/2004 | EP1071397B1 Controlled release peroral compositions of levosimendan |
| 01/28/2004 | EP0968291B1 Antibody fragment-polymer conjugates |
| 01/28/2004 | EP0957900B1 Compositions and methods for topical application of therapeutic agents |
| 01/28/2004 | EP0921789B1 Taste masked liquid suspensions |
| 01/28/2004 | EP0863946B1 Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide) |
| 01/28/2004 | EP0839028B1 Solid dispersions of rapamycin |
| 01/28/2004 | EP0782442B1 A delivery system for antimethanogenic agents comprising cyclodextrin and antimethanogenic agents |
| 01/28/2004 | EP0763124B1 Method for introducing nucleic acid in higher eukaryotic cells |
| 01/28/2004 | EP0708637B1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/28/2004 | CN1471545A Rheology modifying copolymer composition |
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/28/2004 | CN1471390A Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction |
| 01/28/2004 | CN1471388A Milled particles |
| 01/28/2004 | CN1471387A Oral dosage self-emulsifying formulations of pyranone proteinase inhibitors |
| 01/28/2004 | CN1470640A Collagenic protein powder, and its preparing method and use |
| 01/28/2004 | CN1470289A Polymeric nano medicine carrier and preparation preparing method |
| 01/28/2004 | CN1470288A Medical use of paramagnetic material |
| 01/28/2004 | CN1470246A Liquid antiacid composition |
| 01/28/2004 | CN1470238A Levosimendan formulation and its preparing method |
| 01/28/2004 | CN1470233A Water-soluble medicine particle-type slow-release composition, preparation and its preparing method |
| 01/28/2004 | CN1136010C Method for making Subunit antigen vaccine cream |
| 01/28/2004 | CN1136009C Film Coating agent insoluble colour material addition method |
| 01/28/2004 | CN1135981C Morphine sulphate microgranules, and method for making same and pharmaceutical preparations |
| 01/28/2004 | CN1135970C Use of micro particles having a protein and an antiboby absorbed theron for preparing a pharmaceutical composition for intranasal administration |
| 01/28/2004 | CN1135969C Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water |
| 01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 01/27/2004 | US6683144 Salts of acrylamidoalkylsulfonic acids and cyclic or linear n-vinylcarboxamides monomers with crosslinkers having multiple double bonds; thickeners, emulsion and dispersion stabillizers and as glidants in cosmetic and pharmaceuticals |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683100 Organic compounds |
| 01/27/2004 | US6683070 Suspension of water insoluble drug and water soluble polymer; reducing drug concentration, surface tension |
| 01/27/2004 | US6683067 Formulations for treating or preventing mucositis |
| 01/27/2004 | US6683065 Method of treating body insect infestation |
| 01/27/2004 | US6683064 First polysaccharide crosslinked to second polysaccharide, selected from hyaluronic acid, dextran, dextran sulfate, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin, heparan sulfate and alginate |
| 01/27/2004 | US6683062 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 01/27/2004 | US6683059 Constructs for suppression of oncogenic transformation, tumorigenesis and metastasis |
| 01/27/2004 | US6683052 Lipopeptides containing an interferon-γ fragment, and uses thereof in pharmaceutical compositions |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682761 Water-insoluble drug particle process |
| 01/27/2004 | US6682759 Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |